Upregulation of metallothionein-I mRNA expression in a rodent model for amyotrophic lateral sclerosis

Biological Trace Element Research

Volumn 113, Issue 1, 2006, Pages 93-103

  Ono, Shin Ichi ^a   Endo, Yuko ^a   Tokuda, Ei Ichi ^a   Ishige, Kumiko ^b   Tabata, Kei Ichi ^a   Asami, Satoru ^a   Ito, Yoshihisa ^b   Suzuki, Takashi ^a  

^a NIHON UNIVERSITY   (Japan)

^b Akiru Municipal General Hospital   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Kidney; Liver; Metallothionein I; Metallothionein III; Rodent model; Spinal cord

Indexed keywords

MESSENGER RNA; METALLOTHIONEIN I; METALLOTHIONEIN III;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DISEASE MODEL; DISEASE PREDISPOSITION; GENE EXPRESSION; KIDNEY; LIVER; MOTONEURON; MOTOR NEURON DISEASE; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PARALYSIS; PROTEIN EXPRESSION; SPINAL CORD; SYSTEMIC DISEASE; TRANSGENIC MOUSE; UPREGULATION;

MUS MUSCULUS; RODENTIA;

EID: 33751166165     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:113:1:93     Document Type: Article

References (20)

1. M. Ascher, M. G. Cherian, C. D. Klaassen, R. D. Palmiter, J. C. Erickson, and A. I. Bush, Metallothionein in brain. The role in physiology and pathology, Toxicol. Appl. Pharmacol. 142, 229-242 (1997).
2. J. Hidalgo, M. Aschner, P. Zatta, and M. Vašák, Roles of the metallothionein family of proteins in the central nervous system, Brain Res. Bull. 55, 133-145 (2001).
3. M. A. Sens, S. Somji, S. H. Garrett, C. L. Beall, and D. A. Sens, Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis, Am. J. Pathol. 159, 21-26 (2001).
4. J. G. Hoey, S. H. Garrett, M. A. Sens, J. H. Todd, and D. A. Sens, Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures, and renal cell cartinoma, Toxicol. Lett. 92, 149-160 (1997).
5. Y. Uchida, K. Takio, K. Titani, Y. Ihara, and M. Tomonaga, The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein, Neuron 7, 337-347 (1991).
6. L. P. Rowland and N. A. Shneider, Medical progress. Amyotrophic lateral sclerosis, N. Engl. J. Med. 344, 1688-1700 (2001).
7. D. R. Rosen, T. Siddique, D. Patterson, et al., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature 362, 59-62 (1993).
8. J-P. Julien, Amyotrophic lateral sclerosis. Unfolding the toxicity of the misfolded, Cell 104, 581-591 (2001).
9. P. C. Wong, C. A. Pardo, D. R. Borchelt, et al., An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria, Neuron 14, 1105-1116 (1995).
10. M. E. Gurney, H. Pu, A. Y. Chiu, et al., Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation, Science 264, 1772-1775 (1994).
11. R. H. Brown, Jr., Amyotrophic lateral sclerosis. Recent insights from genetics and transgenic mice, Cell 80, 687-692 (1995).
12. S. Choudhuri, W. L. Liu, N. E. J. Berman, and C. D. Klaassen, Cadmium accumulation and metallothionein expression in brain of mice at different stages of development, Toxicol. Lett. 84, 127-133 (1996).
13. S-I. Ono, L. Cai, D. J. Koropatnick, and M. G. Cherian, Radiation exposure does not alter metallothionein III isoform expression in mouse brain, Biol. Trace Element Res. 74, 23-30 (2000).
14. R. D. Palmiter, S. D. Findley, T. E. Whitmore, and D. M. Durnam, MT-III. A brain specific member of the metallothionein gene family, Proc. Natl. Acad. Sci. USA 89, 6333-6337 (1992).
15. J. Y. Tso, X. H. Sun, T. H. Kao, K. S. Reece, and R. Wu, Isolation and characterization of rat and human glyceraldehydes-3-phosphalte dehydrogenase cDNAs, Nucleic Acid Res. 13, 2485-2502 (1985).
16. P. A. E. Sillevis Smitt, H. G. T. Blaauwgeers, D. Troost, and J. M. B. Vianney de Jong, Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis, Neurosci. Lett. 144, 107-110 (1992).
17. P. A. E. Sillevis Smitt, T. P. J. Mulder, H. W. Verspaget, H. G. T. Blaauwgeers, D. Troost, and J. M. B. Vianney de Jong, Metallothionein in amyotrophic lateral sclerosis, Biol. Signals 3, 193-197 (1994).
18. Y. H. Gong and J. H. Elliott, Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis, Exp. Neurol. 162, 27-36 (2000).
19. S. Nagano, M. Satoh, H. Sumi, et al., Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner, Eur. J. Neurosci. 13, 1363-1370 (2001).
20. P. A. E. Sillevis, H. van Beek, A-J. Baars, et al., Increased metallothionein in the liver and kidney of patients with amyotrophic lateral sclerosis, Arch. Neurol. 49, 721-724 (1992).